Primary endpoint: The primary efficacy variable will be the difference in physical activity measured in vector magnitude units (VMUs) by the triaxial Stayhealthy RT3 accelerometer at the end of the three month treatment period compared to placebo. [clinicaltrials_resource:2d4c8f52faf04ad30573c74b70bdcaba]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Primary endpoint: The primary efficacy variable will be the difference in physical activity measured in vector magnitude units (VMUs) by the triaxial Stayhealthy RT3 accelerometer at the end of the three month treatment period compared to placebo. [clinicaltrials_resource:2d4c8f52faf04ad30573c74b70bdcaba]
Bio2RDF identifier
2d4c8f52faf04ad30573c74b70bdcaba
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2d4c8f52faf04ad30573c74b70bdcaba
measure [clinicaltrials_vocabulary:measure]
Primary endpoint: The primary ...... nt period compared to placebo.
identifier
clinicaltrials_resource:2d4c8f52faf04ad30573c74b70bdcaba
title
Primary endpoint: The primary ...... nt period compared to placebo.
@en
type
label
Primary endpoint: The primary ...... c8f52faf04ad30573c74b70bdcaba]
@en